References

  1. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012;379(9821):1155-66. PubMed | Google Scholar

  2. Danciulescu Miulescu R, Caraote M, Trifanescu R, Ferechide D, Poiana C. Antithyroid drugs induced agranulocytosis and multiple myeloma: case report and general considerations. J Med Life. 2013; 15(6):327-31. PubMed | Google Scholar

  3. Watanabe N, Narimatsu H, Noh JY, Yamaguchi T, Kobayashi K, Kami M et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. J Clin Endocrinol Metab. 2012 Jan;97(1):E49-53. PubMed | Google Scholar

  4. Federici L, Weitten T, Alt M, Blaison G, Zamfir A, Audhuy B, Maloisel F, Andrès E. Idiosyncratic drug-induced agranulocytosis. Presse Med. 2008;37(9):1327-33. PubMed | Google Scholar

  5. Tajiri J, Noguchi S, Murakami N. Asymptomatic antithyroid induced agranulocytosis,the usefulness of routine CBC monitoring. Arch Intern Med. 1990;150(3): 621-624.. PubMed | Google Scholar

  6. Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, Kaltsas G.Antithyroid drug-induced aplastic anemia. Thyroid. 2008;18(10):1043-8. PubMed | Google Scholar

  7. Tsuboi K, Ueshiba H, Shimojo M, Ishikawa M, Watanabe N, Nagasawa K, Yuasa R, Yoshino G.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease. Endocr J. 2007;54(1):39-43. PubMed | Google Scholar

  8. Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid. 2009;19(6):559-63. PubMed | Google Scholar

  9. Dai WX, Zhang JD, Zhan SW, Xu BZ, Jin H, Yao Y et al. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Endocr J. 2002 49(1):29-33. PubMed | Google Scholar

  10. Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid. 2005;15(3):292-7. PubMed | Google Scholar

  11. Talbert RL, Sherman SI. Thyroid disordersi, DiPiro JT, Talbert R, Yee G et al, Phramacotherapy, A Pathophsiologic.Approach.7th ed. New York: McGraw-Hill Medical;2008.Available at ;http;//www.accesspharmacy.com/content.aspx. Accessed on November 04 2015. Google Scholar